pirarubicin and Hemangiosarcoma

pirarubicin has been researched along with Hemangiosarcoma* in 2 studies

Other Studies

2 other study(ies) available for pirarubicin and Hemangiosarcoma

ArticleYear
Primary cardiac angiosarcoma: 53 months' survival after multidisciplinary therapy.
    The Annals of thoracic surgery, 1997, Volume: 63, Issue:4

    An 8-year-old girl underwent surgical excision of a tumor arising from the right atrium immediately after admission. Because histologic and immunohistochemical examination confirmed the diagnosis of angiosarcoma, adjunctive multidisciplinary therapy was administered for the following 2 years. She is leading a normal school life 53 months after the operation. Therapeutic strategy for this highly malignant cardiac tumor is discussed.

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Heart Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Survivors; Time Factors

1997
Treatment of disseminated hepatoblastoma involving bilateral lobes.
    Journal of pediatric surgery, 1990, Volume: 25, Issue:12

    A 30-month-old boy was investigated because of a huge abdominal mass in the right upper abdomen. A computed tomography scan and celiac angiography showed that the tumor involved bilateral lobes of the liver. At first, for this disseminated and "unresectable" tumor we did liver biopsy and hepatic arterial catheterization. Through this catheter we started chemotherapy using THP-Adriamycin and cis-platinum. After three courses of chemotherapy, a second-look operation was performed and trisegmentectomy was done to remove the main tumor and metastases, including the left lobe and the right anterior segment. The trisegmentectomy was performed with success, and the boy's serum alpha-fetoprotein (AFP) remains normal 37 months after the start of treatment, indicating a probable permanent cure. Such cases have rarely been reported in the literature. Our experience in treating this patient would seem to encourage aggressive management of advanced hepatoblastoma in other patients.

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Doxorubicin; Hemangiosarcoma; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male

1990